Clinical Trial 1567

Tucson, AZ 85712

Study Summary:

We are conducting a multicenter, randomized, double-blind study to compare the efficacy and safety of patient-initiated Famciclovir 1000mg bid x 1 day to Valacyclovir 500mg bid x 3 days in immunocompetent adults with recurrent genital herpes.

Qualified Participants Must:

• Be 18 years of age or older
• Have recurrent genital herpes at least 4 outbreaks per year
• Be willing to stop suppressive treatment at visit 1

Qualified Participants May Receive:

25.00 per visit up to 325.00 for completion of study

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.